Cell Separation Technologies Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4316
Cell Separation Technologies Market size is expected to grow significantly from 2019 to 2025.
Increasing prevalence of chronic diseases such as cancer and diabetes worldwide coupled with technological advancements in cell separation technique accelerates cell separation technologies market growth. Treatment and diagnosis of chronic diseases requires analysis of typical cell behavior. Whereas isolated cells increases the sensitivity of analytical methods by genetic modification and expansion of a desired cell type for disease modelling. Several such factor boosts cell separation technologies industry growth.
Rapidly rising demand for cell based and gene therapies will propel the cell separation technologies market growth. Furthermore, funding from government sector proves beneficial for the industry players to introduce novel technologies including EasySep. It combines the specificity of monoclonal antibodies with column-free magnetic system and allows cell depletion that should positively impact business growth. However, lack of skilled workforce may hamper the cell separation technologies market growth during the analysis period.
Immunomagnetic cell separation segment will witness lucrative growth over foreseeable future. Immunomagnetic cell separation is commonly used cell separation technique among scientists. Various advantages offered over alternatives such as high purity, fast protocols, ease of use as well allows isolation of many cells at once. Above mentioned factor thereby augment segmental growth.
Oncology segment will witness remarkable growth over the analysis timeframe owing to increasing incidence of cancer and geriatric population base susceptible to acquire cancer. Emerging cell therapy practices ensures efficient patient management for these life-threatening diseases thereby foster segment growth. Moreover, focus of manufactures on developing innovative gene therapies in the field of oncology boosts industry growth.
Biotech and pharmaceutical company segment will witness significant growth over forthcoming years on an account of increasing demand for technologically advanced cell-based therapies. Moreover, adoption of advanced instruments and consumables in pharmaceutical and biotechnology companies for cancer research and experiments along with R&D investments boosts the segment growth.
North America cell separation technologies industry will witness lucrative revenue share by 2025. Increasing incidence of chronic diseases and growing cell-based therapies will surge the demand for cell separation technologies in developed region. Furthermore, increasing government investments in public and private healthcare infrastructure will prove beneficial for the industry players to introduce novel cell separation technologies.
Prominent players working in cell separation technologies industry include Akadeum life science, STEMCELL Technologies, Bio-Rad Laboratories, Miltenyi Biotech, Thermo Fisher Scientific, Zeiss, GE Healthcare, PerkinElmer and EMD Millipore. Business players are adopting numerous strategies including acquisitions and collaborations to sustain market competition. For instance, in 2018 Akadeum Life Sciences announced advancements of next generation cell isolation technologies. Company successfully demonstrated microbubble for isolation of human T cell.
Cell Separation Technologies Market By Technology, 2014-2025 (USD Million)
- Fluorescence Activated Cell Sorting (FACS)
- Density Gradient Centrifugation
- Immuno-Magnetic Cell Separation
- Micro Fluidic Cell Separation
- Immuno-Density Cell Separation
Cell Separation Technologies Market By Application, 2014-2025 (USD Million)
- Neuroscience Research
- Oncology Research
- Stem Cell Research
- Microbiology Research
- Immunobiology Research
Cell Separation Technologies Market By Product, 2014-2025 (USD Million)
Cell Separation Technologies Market By End-use, 2014-2025 (USD Million)
- Diagnostic Centers
- Biotech and Pharmaceutical company
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Akadeum life science
- STEMCELL Technologies
- Bio-Rad Laboratories
- Miltenyi Biotech
- Thermo Fisher Scientific
- GE Healthcare
- EMD Millipore
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.